Literature DB >> 17488186

Physician-level P4P--DOA? Can quality-based payment be resuscitated?

Laurence F McMahon1, Timothy P Hofer, Rodney A Hayward.   

Abstract

Unlike many areas of the economy where value is relatively easy to measure and reward, healthcare is "messy." Patients bring both clinical heterogeneity and illness-severity complexities to the interchange with their physician. The measurable outcomes or process measures are as likely to be due to patient characteristics as they are to be due to the actions (or inactions) of the patient's provider. Moreover, data suggest that the simplest fix for providers with bad metrics is to "dump" their sickest patients. Perhaps the most pernicious consequence of physician-level pay-for-performance (P4P) systems is how these systems can affect the neediest patients and their providers. As patient characteristics (eg, illness severity, preferences, resources) are more likely to be an issue in our poorer and minority communities, these patients' physicians will be at a financial disadvantage in a P4P system. It is likely that the widespread adoption of P4P systems will further limit these necessary resources.

Entities:  

Mesh:

Year:  2007        PMID: 17488186

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  4 in total

1.  Multiple chronic conditions and disabilities: implications for health services research and data demands.

Authors:  Lisa I Iezzoni
Journal:  Health Serv Res       Date:  2010-08-02       Impact factor: 3.402

2.  Measuring value in primary care: enhancing quality or checking the box?

Authors:  Renuka Tipirneni; Laurence F McMahon
Journal:  Health Serv Res       Date:  2014-12       Impact factor: 3.402

3.  Lessons from the Rise-and Fall?-of VA Healthcare.

Authors:  Rodney A Hayward
Journal:  J Gen Intern Med       Date:  2017-01       Impact factor: 5.128

4.  The impact of concordant and discordant conditions on the quality of care for hyperlipidemia.

Authors:  Tara Lagu; Mark G Weiner; Christopher S Hollenbeak; Susan Eachus; Craig S Roberts; J Sanford Schwartz; Barbara J Turner
Journal:  J Gen Intern Med       Date:  2008-05-09       Impact factor: 5.128

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.